Abstract
The therapeutic effect of antifungal agent, 3-(p-methylbenzylideneamino)-4-phenylthiazoline-2-thione referred as TBK hereafter, was clinically tested on some kinds of tinea. TBK preparations, in a form of carbowax ointment containing one (TBK I) or two (TBK II) percent, was applied. Of 30 subjects tested, there were 19 Tinea cruris, 10 T. interdigitalis and 14 T. pedis. TBK I was applied in 10 subjects and TBK II in 7. In the rest, both preparations were used—different lesions of same individual—for comparison of efficacy according to the concentrations. The therapeutic effects of TBK I and TBK II were 70% and 89% for T. cruris, 71% and 100% for T. interdigitalis, and 17% and 33% for T. pedis, respectively. As to side effects, contact dermatitis was observed only in a patient with T. cruris treated by TBK II.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
